Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL
- Status
- COMPLETED
- Phase
- PHASE1
CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
- Status
- UNKNOWN
- Phase
- N/A
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
- Status
- COMPLETED
- Phase
- PHASE1
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
- Status
- UNKNOWN
- Phase
- PHASE4
An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1
Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment
- Status
- COMPLETED
- Phase
- N/A
Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
- Status
- TERMINATED
- Phase
- PHASE4
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2